We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Acetowhitening Display Software for Cervical Colposcopic Examination

By HospiMedica International staff writers
Posted on 26 Jan 2011
New software digitizes and memorializes acetowhitening to enhance physicians' viewing during cervical colposcopic exams.

The ImageSense software, available for the UltraSightHD digital colposcopy system, produces a digital output that depicts color differences of the cervix before and after the application of acetic acid during a colposcopic exam. More...
By digitizing and memorializing an otherwise transient effect, and enabling on-demand viewing of the acetowhite process, the image can be used by clinicians to identify areas of the cervix possibly containing disease.

The UltraSight HD Digital Colposcopy System possesses an intuitive touch screen interface that offers an optimal viewing angle and an on screen display (OSD) menu that enables users to annotate high-definition (HD) images, and then save them as part of the electronic health record (EHR). An adaptable viewing screen controlled by the physician enables the patient to also see what the physician sees. The ImageSense software and the UltraSightHD digital colposcopy system are products of STI Medical Systems (Honolulu, HI, USA), and have been approved by the US Food and Drug Administration (FDA).

"Its high-definition imagery takes wonderful ‘archive quality' cervical exam images, and the ability to perform annotations during the exam on the device's touch screen saves physician time,” said Nathan Fujita, MD, of The Queen's Medical Center (Honolulu, HI, USA).

Acetowhitening refers to the blanching of skin or mucous membranes after application of 3% to 5% acetic acid solution, and indicates increased cellular protein and increased nuclear density. It is used particularly on genital skin and mucous membranes, including the uterine cervix, to identify zones of squamous cell change for biopsy and condyloma acuminatum for treatment.

Related Links:
STI Medical Systems
The Queen's Medical Center


Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Newborn Hearing Screener
ALGO 7i
PACS Workstation
PaxeraView PRO
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.